Cargando…

E2F1 inhibition mediates cell death of metastatic melanoma

Melanoma is one of the most lethal cancers when it reaches a metastatic stage. Despite advancements in targeted therapies (BRAF inhibitors) or immunotherapies (anti-CTLA-4 or anti-PD1), most patients with melanoma will need additional treatment. Thus, there is an urgent need to develop new therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rouaud, Florian, Hamouda-Tekaya, Nedra, Cerezo, Michaël, Abbe, Patricia, Zangari, Joséphine, Hofman, Veronique, Ohanna, Mickaël, Mograbi, Baharia, El-Hachem, Najla, Benfodda, Zohra, Lebeau, Alexandre, Tulic, Meri K., Hofman, Paul, Bertolotto, Corine, Passeron, Thierry, Annicotte, Jean-Sébastien, Ballotti, Robert, Rocchi, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943238/ https://www.ncbi.nlm.nih.gov/pubmed/29743521 http://dx.doi.org/10.1038/s41419-018-0566-1

Ejemplares similares

Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
por: Ohanna, Mickaël, et al.
Publicado: (2018)

Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies
por: Jaune, Emilie, et al.
Publicado: (2021)

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition
por: Zangari, Joséphine, et al.
Publicado: (2018)

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition
por: Zangari, Joséphine, et al.
Publicado: (2017)

Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib
por: Lehraiki, Abdelali, et al.
Publicado: (2015)

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021)

ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
por: Cheli, Yann, et al.
Publicado: (2021)

Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo
por: Tulic, Meri K., et al.
Publicado: (2019)

Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives
por: Martel, Arnaud, et al.
Publicado: (2020)

An Update on the Role of Ubiquitination in Melanoma Development and Therapies
por: Soysouvanh, Frédéric, et al.
Publicado: (2021)

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells
por: Ohanna, Mickaël, et al.
Publicado: (2014)

The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
por: Mograbi, Baharia, et al.
Publicado: (2021)

More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021)

Using Genetics To Dissect SARS-CoV-2 Infection
por: Brest, Patrick, et al.
Publicado: (2021)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment
por: Heeke, Simon, et al.
Publicado: (2019)

Impact of topical emollient, steroids alone or combined with calcipotriol, on the immune infiltrate and clinical outcome in psoriasis
por: Heim, Marjorie, et al.
Publicado: (2022)

Host Polymorphisms May Impact SARS-CoV-2 Infectivity
por: Brest, Patrick, et al.
Publicado: (2020)

Host genetic variability and determinants of severe COVID-19
por: Brest, Patrick, et al.
Publicado: (2023)

Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective
por: Boniface, Katia, et al.
Publicado: (2021)

From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer
por: D'Andréa, Grégoire, et al.
Publicado: (2021)

The “ART” of Epigenetics in Melanoma: From histone “Alterations, to Resistance and Therapies”
por: Strub, Thomas, et al.
Publicado: (2020)

The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
por: Ballotti, Robert, et al.
Publicado: (2020)

The pro-tumoral function of HACE1
por: El-Hachem, Najla, et al.
Publicado: (2018)

Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes
por: Bertolotto, Corine, et al.
Publicado: (1998)

Recent advances in understanding the role of HES6 in cancers
por: Krossa, Imène, et al.
Publicado: (2022)

Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
por: Martel, Arnaud, et al.
Publicado: (2023)

Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype
por: Ohanna, Mickaël, et al.
Publicado: (2013)

Immune Checkpoints in Cancers: From Signaling to the Clinic
por: Pisibon, Céline, et al.
Publicado: (2021)

Ceramide AD™ Restores Skin Integrity and Function following Exposure to House Dust Mite
por: Bzioueche, Hanene, et al.
Publicado: (2023)

HIF1A regulates xenophagic degradation of adherent and invasive Escherichia coli (AIEC)
por: Mimouna, Sanda, et al.
Publicado: (2015)

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
por: Martel, Arnaud, et al.
Publicado: (2023)

Focus on cutaneous and uveal melanoma specificities
por: Pandiani, Charlotte, et al.
Publicado: (2017)

Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
por: Krossa, Imène, et al.
Publicado: (2022)

From benchmarking HITS-CLIP peak detection programs to a new method for identification of miRNA-binding sites from Ago2-CLIP data
por: Bottini, Silvia, et al.
Publicado: (2017)

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells
por: Habel, Nadia, et al.
Publicado: (2021)

Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?
por: Giuliano, Sandy, et al.
Publicado: (2023)

Green methodologies for the synthesis of 2-aminothiophene
por: Duvauchelle, Valentin, et al.
Publicado: (2022)

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5
por: Giuliano, Sandy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uch34tulpf5apici15c6rqgkrs